40,000 Equity Shares Allotted to Promoter on Warrant Conversion

Warrants ConvertedFund Raising View source PDF

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

-0.5%1-day move

₹1830.00

prior close

—

base price

After-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

————-0.5-4.4-1.9+1.1+14.2+15.2+37.9+38.2+27.0+42.2

Up moveDown movePending

AI summary

Fredun Pharmaceuticals allotted 40,000 equity shares (face value ₹10) to promoter Mrs. Daulat Nariman Medhora upon conversion of warrants originally allotted on Dec 29, 2025. The promoter paid the remaining 75% consideration of ₹937.50 per warrant, totaling ₹3.75 crore, at an issue price of ₹1,250 per share (premium of ₹1,240). No warrants remain outstanding for conversion. Shares will rank pari passu with existing equity and are in dematerialized form.

Likely market impact

Minor dilution; signals promoter confidence as conversion completed at ₹1,250/share, no warrants left outstanding.